A Phase II, randomized, comparative trial of standard of care, with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplantation in patients with FLT3-ITD mutated acute myeloid leukemia - Regional Cancer Care Associates LLC

Clinical Trials

A Phase II, randomized, comparative trial of standard of care, with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplantation in patients with FLT3-ITD mutated acute myeloid leukemia

Type of Cancer
Leukemia
Locations
Hackensack
Sponsor
Novartis
Protocol Number
CPKC412AUS23
Cancer Diagnosis
To Learn More Call
201-510-0910